Market Overview

Benzinga's Volume Movers

Related CGIX
RedChip Issues Research Update on Cancer Genetics
Cancer Genetics, Inc. Receives New York State Licensure for FHACT Cervical Cancer Test
Meridian Bioscience Wins CE Mark for Herpes Virus Assays - Analyst Blog (Zacks)
Related GPN
Benzinga's Top Initiations
CLSA Initiates Global Payments At Underperform
Growth In The Era Of Human Capital (Seeking Alpha)

Cancer Genetics (NASDAQ: CGIX) shares moved up 6.38% to $20.85. The volume of Cancer Genetics shares traded was 1637% higher than normal. Cancer Genetics is expected to post revenue of $ 18.65 million in the year ending December, 2014.

Global Payments (NYSE: GPN) shares rose 9.25% to $55.39. The volume of Global Payments shares traded was 1130% higher than normal. Global Payments reported upbeat fiscal first-quarter results and raised its annual forecast. The company named Jeffrey S. Sloan as its new chief executive and announced its plans to buy back up to $100 million of its common stock.

Rockwell Medical (NASDAQ: RMTI) shares climbed 7.69% to $12.32. The volume of Rockwell Medical shares traded was 482% higher than normal. Rockwell Medical reported that the Phase 3 CRUISE study data has been accepted as a Late-Breaking Clinical Trial.

Allot Communications (NASDAQ: ALLT) surged 11.80% to $14.12. The volume of Allot Communications shares traded was 459% higher than normal. Allot Communications reported that it has received a new multimillion dollar order from a US-based cloud provider.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (ALLT + CGIX)

Around the Web, We're Loving...